The current status,challenges and strategies of China's innovative drug exports to Association of Southeast Asian Nations——A PEST analysis
WANG Zhang-ke
PEI Xiao-yu
XING Bing-ke
SHENG Tian-yi
JIANG Rong
SHAO Rong
Abstract：With the increasing exchanges between China and Association of Southeast Asian Nations(ASEAN),ASEAN has emerged as a significant market for China's innovative drug exports.This analysis is based on a PEST analysis of the pharmaceutical market environment in ASEAN.However,China's export of innovative drugs to this region faces several challenges,including the necessity for country-specific applications,misalignment between enterprise expectations and individual national markets,the differences in internal business environment,differing technical requirements,and competitive pressure from European and American enterprises on the same platform.To address these challenges,it is suggested that communication between the governments of China and ASEAN be strengthened.Additionally,efforts should be made to increase international recognition for Chinese pharmaceuticals.Cooperation should be prioritized with countries that support innovation,and initiatives shold be undertaken to facilitate exchanges between enterprises in China and ASEAN.These measures aim to promote smoother entry of innovative medicines into the ASEAN market.
Keywords：Association of Southeast Asian Nationsdrug exportstrade barriersmedicinemarket
Publication Date：2026-01-30
Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)
Pages：8( 141-148 )